Abingdon Health (LON:ABDX) Announces Quarterly Earnings Results

Abingdon Health (LON:ABDX) announced its quarterly earnings data on Monday. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Price Performance

ABDX traded down GBX 0.19 ($0.00) during midday trading on Wednesday, reaching GBX 6.31 ($0.08). 259,223 shares of the company’s stock were exchanged, compared to its average volume of 135,712. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The business has a 50-day simple moving average of GBX 7.46 and a two-hundred day simple moving average of GBX 7.96. The firm has a market capitalization of £12.22 million, a price-to-earnings ratio of -15.34 and a beta of 0.13. Abingdon Health has a one year low of GBX 6 ($0.08) and a one year high of GBX 11.75 ($0.15).

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.